decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / PERCUTANEOUS_IMAGE-GUIDED_BREAST_BIOPSY
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare coverage policy for percutaneous image-guided breast biopsy under the National Coverage Determinations Manual. It is relevant to radiology, breast imaging, pathology-related workflow, and coding staff who need to understand the general coverage scope, the imaging approaches discussed, and the reporting framework referenced by the policy. The article also identifies the effective date and distinguishes between broad lesion categories addressed in the coverage language.
Why This Topic Matters
Coverage policies shape when services are payable and how imaging-based breast biopsy cases are understood within Medicare policy. This makes the article useful for clinicians, coders, compliance teams, and revenue cycle staff working with breast imaging and biopsy services.
Article Sections
-
Percutaneous Image-Guided Breast Biopsy 220.13
Introduces the Medicare coverage topic and describes the procedure at a high level. The section frames the policy context for image-guided breast biopsy.
-
Nonpalpable Breast Lesions
Addresses coverage guidance for one broad category of breast lesions and notes the associated effective date. The section references mammography reporting categories used in the policy context.
-
Palpable Breast Lesions
Addresses coverage guidance for a second broad category of breast lesions and notes the associated effective date. The section discusses the policy context for cases that are difficult to evaluate by palpation alone.
What You Will Learn
- The Medicare coverage context for image-guided breast biopsy
- How the article distinguishes broad categories of breast lesions
- What imaging guidance approaches are referenced in the policy
- Which reporting framework is mentioned in relation to mammography
- The effective date associated with the coverage discussion
Who Should Read This
- Medical coders
- Radiology and breast imaging staff
- Compliance professionals
- Revenue cycle staff
- Physicians involved in breast biopsy services
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com